Haemodialysis patients have high levels of the inactive form of MGP ( desphosphorylated-uncarboxylated-MGP , dp-uc-MGP ) and may benefit from pharmacological doses of vitamin K2 ( menaquinone ) to improve the calcification inhibitory activity of MGP .